Ameritas Investment Partners, Inc. Surface Oncology, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.42 - $3.15 $3,704 - $8,218	-2,609 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$6.45 - $9.09 $16,828 - $23,715	2,609 New	2,609 $19,000
Q2 2019 Aug 14, 2019	SELL	$2.75 - $4.89 $1,559 - $2,772	-567 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$12.83 - $17.41 $7,274 - $9,871	567 New	567 $9,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.